Matsusue Takeo
1 Department of Plastic and Reconstructive Surgery, Kansai Electric Power Hospital, Osaka, Japan.
J Hand Surg Asian Pac Vol. 2019 Mar;24(1):1-5. doi: 10.1142/S2424835519500012.
Antithrombotic therapy following replantation remains controversial, and the survival of replanted digits is affected by various other factors, such as the state of vascular damage and the surgeon's level of skill. The present study's aim is to obtain clinical evidence for postoperative antithrombotic therapy in replantation, with antithrombotic therapy being the only variable.
This was a single-center retrospective study of patients who underwent replantation of a completely amputated digit by the same surgeon. The subject sample included 17 patients/19 digits (group A) in whom heparin and prostaglandin E1 (PGE1) were used postoperatively during a 1-year period, 19 patients/22 digits (group B) in whom heparin was not used postoperatively but PGE1 was used for a 1-year period, and 16 patients/19 digits (group C) in whom neither heparin not PGE1 were used postoperatively for a 1-year period.
Patient background and surgical procedure were not significantly different among groups, and only the postoperative use of heparin and/or PGE1 showed differences. Incidence of arterial occlusion, venous occlusion, or vascular spasm were not significantly different among groups (arterial occlusion: 1 digit in group A, 2 in group B, and two in group C, p = 1; venous occlusion: 1 digit in group A, 2 in group B, and three in group C, p = 0.67; vascular spasm: 1 digit in group A, 2 in group B, and one in group C, p = 1). Postoperative bleeding was significantly more common in the group using heparin (7 patients in group A, 0 in group B, and zero in group C, p < 0.001).
These results suggest that heparin and PGE1 administration do not improve impaired blood flow following replantation. Considering the potential complications, heparin and PGE1 following replantation do not seem necessary.
再植术后的抗栓治疗仍存在争议,而再植指体的存活受多种其他因素影响,如血管损伤状况和外科医生的技术水平。本研究的目的是获得再植术后抗栓治疗的临床证据,其中抗栓治疗是唯一变量。
这是一项单中心回顾性研究,研究对象为同一外科医生进行完全离断指再植术的患者。研究样本包括17例患者/19根手指(A组),在1年期间术后使用肝素和前列腺素E1(PGE1);19例患者/22根手指(B组),术后未使用肝素但使用PGE1达1年;16例患者/19根手指(C组),术后1年既未使用肝素也未使用PGE1。
各组患者的背景和手术操作无显著差异,仅术后肝素和/或PGE1的使用存在差异。各组动脉闭塞、静脉闭塞或血管痉挛的发生率无显著差异(动脉闭塞:A组1根手指,B组2根,C组2根,p = 1;静脉闭塞:A组1根手指,B组2根,C组3根,p = 0.67;血管痉挛:A组1根手指,B组2根,C组1根,p = 1)。使用肝素的组术后出血明显更常见(A组7例患者,B组0例,C组0例,p < 0.001)。
这些结果表明,肝素和PGE1给药并不能改善再植术后受损的血流。考虑到潜在并发症,再植术后使用肝素和PGE1似乎没有必要。